Introduction
Huntington's disease (HD)' is a progressive neurodegenerative disorder causing progressive loss of motor control, impaired cognition, and psychiatric disturbance (1) . The neuropathologic hallmark of the disorder is marked atrophy of the basal ganglia, particularly the caudate nucleus. HD is caused by an autosomal dominant genetic defect, but the disease gene has not yet been isolated and the biochemical basis for neuronal cell loss in the disorder is not understood. There is no effective treatment for delaying or preventing the manifestations of HD which typically begin in the fourth or fifth decade oflife. Linkage analysis with DNA markers has localized the site of the genetic defect to the tip of the chromosome 4 short arm, 3-4 cM distal to the anonymous DNA marker D4S10 (2) (3) (4) . Two additional polymorphic markers D4S43, and D4S95, have recently been located closer to the telomere than D4S10 and both show very tight linkage with the disease gene (5, 6) .
The characterization of linked markers for HD has introduced the possibility ofdiagnosing the presence ofthe defect in 1. Abbreviations used in this paper: HD, Huntington's disease; RFLP, restriction fragment length polymorphism; VNTR, variable number of tandem repeats.
gene camers before the onset of reliable clinical signs (7, 8) . The difficult task of making an informed choice concerning predictive testing has prompted the initiation of programs in a number of centers to provide the intensive counselling required. In many cases, however, the modification of genetic risk that can be achieved by DNA typing is limited by family structure, and by the informativeness of the linked markers. For presymptomatic and prenatal diagnosis of HD to be widely applied, it is critically important to increase the number and informativeness of linked DNA markers to ensure a rapid and accurate test. We have therefore searched for new RFLPs at the D4S43 locus (5), and two loci mapped to the HD region by physical techniques, D4S11I1 and D4S1 15 (9). In each case, we have identified one or more RFLPs with the characteristics of VNTR (variable number of tandem repeats) markers (10), multiple alleles that can be visualized using any of several restriction enzymes. We have also found that an independently isolated VNTR marker, D4S 125 (11) , also maps near the HD gene. The availability of a plethora of highly informafive multiallele markers should have a profound impact on increasing the accuracy and applicability of presymptomatic and prenatal diagnosis of HD while reducing the time and cost of this stressful procedure.
Methods
DNA probes and hybridization. For the D4S43 locus, two single copy probes were used: (a) pKPl.65 is a 1.7-kb Pst I fragment subcloned from cosmid clone C39 into pGEM3; (b) pXP500 is a single-copy 0.5-kb Xba I-Pst I fragment from cosmid C31 (subcloned into pGEM4) which detects the same multiallele RFLP previously described for probe Sma2.6 (5). p252.3 is a 800 bp Pst I-Sau 3A fragment from a cosmid which overlaps the NotI-linking clone 252 (9) at the D4S1 15 locus. p157.9 is a 450 bp Pst I-Sau3A fragment sucloned into pGEM3 from a cosmid that overlaps the Not I-linking clone 157 (9) defining D4S 111. A second probe for this locus, S281, is a 2.3 kb Eco RI fragment excised from the adjacent cosmid S28. The probes YNZ32 representing D4S125 and pBS674 representing D4S95 have been described previously (6, 11, 12) .
Genomic DNA for RFLP typing was extracted from cultured lymphoblasts as previously described (13) . Agarose gel electrophoresis, DNA transfer, hybridization, and autoradiography were performed as described (2) casians and 61 unaffected parents of HD patients, though not all individuals were typed for all marker loci. Heterozygosity in the HD population was determined by typing the 61 unrelated HD patients. The estimate of linkage distance between each marker locus and the HD gene was obtained by typing the Venezuela HD kindred and several smaller pedigrees from the United States and Europe (2, 3, 16) . Lod scores indicating the log of the relative likelihood of linkage were calculated using the LINKAGE program (17) . An age of onset correction was used for all calculations involving the HD locus (2, 18) . The maximum lod score (£) denotes the maximum likelihood estimate 0 of the recombination frequency between the marker and the disease gene. The l-lod unit confidence interval on this estimate of 0 approximates the 95% confidence limits (19) . To maximize the linkage information for the D4S43 locus, previously reported RFLPs were included in a haplotype with the multiallele RFLPs, including a very rare Sau 96I RFLP segregating with HD in the Venezuela kindred (5). Since D4SI1 11 and D4S1 15 are 250 kb apart (9) and are extremely tightly linked, with no recombinants in 179 informative meioses in reference pedigrees, the two were haplotyped as a single locus for this analysis.
Results
The mapping of DNA probes using specially constructed somatic cell hybrid panels (12, 20) has provided a number of loci distal to D4S10 in 4p16.3, the terminal cytogenetic subband of the chromosome 4 short arm. Two ofthese, D4S43 and D4S95 have been shown to be more tightly linked to HD than D4S10 (5, 6) . In this study, we have concentrated on expanding the previously described D4S43 locus, and on finding RFLPs for D4S11I1 and D4S 1 15 , two loci representing NotI-linking clones mapped by physical means distal to D4S10 and D4S43 (9). We have also used the somatic cell hybrid mapping panel to assign D4S 125 (11) , an independently isolated VNTR marker, to the terminal 4p16.3 band.
The D4S43 locus was originally defined by the single copy probe C4H chosen from a X phage library enriched for chromosome 4 sequences (21). The region was then expanded to 1 I08 kb by cosmid walking, permitting the identification ofa (Table I) . Similar but independent VNTR-like RFLPs were found when probes from cosmids overlapping two Not I-linking clones were used (Table I and Fig. 1 ). These probes pl 57.9 and p252.3 define the loci D4S111 and D4S 115, respectively, which are located 250 kb apart, and are both distal to D4S43. A second multi-allele RFLP for D4S1 1 1 was detected by the probe pS281, derived from an adjacent cosmid clone. Since D4S95 also reveals a multiallele RFLP, this study brings to seven the number of such polymorphisms located in 4pl6.3. The high frequency of VNTR markers identified without any means of enrichment suggests that such polymorphisms may be preferentially located toward telomeres.
In any given predictive test, it is crucial that the affected parent of the "at risk" individual be heterozygous for the marker locus. To estimate the frequency with which individuals carrying the HD gene are heterozygous for one or more of the multiallele systems, we have typed 61 unrelated HD patients. All 61 individuals were heterozygous for at least one marker. To assess heterozygosity in the normal population, we typed the unaffected parents ofthe HD individuals, along with 39 randomly chosen North Americans from non-HD families. None of these 100 non-HD individuals was homozygous for all seven multiallele RFLPs indicating that the capacity to distinguish any two chromosome 4s approaches 100%. Like previously characterized RFLPs in the 4p16.3 region, none of Table II . This analysis indicates that each of the newly described loci is tightly linked to the disease gene, with predicted recombination estimates ranging from 1 to 3 cM.
A major benefit of multiallele systems is the potential for typing several loci using the same restriction enzyme. Given the stress on the at risk individual and his family imposed by the presymptomatic testing process, the turn-around time for DNA typing should ideally be as short as possible. Consequently, we have tested the feasibility of simultaneous hybridization of several probes to the same blots for more rapid processing of test samples. Fig. 1 
Discussion
The linked marker D4S10 has been applied successfully to presymptomatic diagnosis of HD, but the accuracy of prediction has been limited by the measurable recombination between the marker and HD, and by the lack of a flanking marker (8) . A further complication of utilizing two allele systems is their limited capacity to detect nonpaternity in the ragged incomplete pedigrees typical of at risk individuals requesting preclinical testing. Finally, the procedure using D4S10 is costly and tedious, since it requires typing family members for many different RFLP sites with several different restriction enzymes to maximize the potential for an informative test. The addition of RFLPs for D4S43 and D4S95 has increased the applicability of the predictive test, but even so, many cases still yield equivocal or uninformative results, further complicating the already difficult task of genetic counselling in this situation.
The characterization of the five multiallele RFLPs described here promises to alleviate these difficulties. The markers can be typed using any of a number of restriction enzymes, some ofwhich are in common for each other and for certain D4S1O RFLPs. Thus, sequential or even simultaneous hybridization of a single Southern blot can potentially replace the numerous blots required previously. The high level of heterozygosity observed with these markers will also increase the proportion of tests that are informative and accelerate the testing process. Moreover, the fact that all the new RFLPs are distal to D4S1O and much closer to HD confers a significant increase in the predictive accuracy of test results.
The relative order of these loci on the physical map of 4p16.3 is already known from pulsed-field gel mapping experiments, although the precise distances separating the markers has not been determined in all cases (Bucan et al., manuscript submitted for publication). Similarly, some of the loci have been genetically ordered by linkage analysis in reference pedigrees (23) . The combined information from these two complementary methods indicates the following linear order: centromere-D4S 1 0-D4S 1 25-D4S95-D4S43-D4SI 15-D4S1 1 1-telomere with the region D4S 125 to D4S1 1 1 spanning only -2 cM.
Typing of these markers against individual recombination events in HD pedigrees indicates that the disease gene is distal to D4S125, D4S95, and D4S43 (24) but cannot be unequivocally placed relative to D4S 1 15 and D4S 111(23) . Two recombination events suggest a terminal location for HD while one supports the view that D4S11I1 and D4S1 15 might flank the disease gene on the telomere side. Until this ambiguity has been resolved, these latter loci should not be assumed to flank the disease gene. We urge that at present a conservative recombination estimate of 3% be used for all of these markers when they are used in genetic counseling.
